Course of disability and respiratory function in untreated late-onset Pompe disease
- 28 February 2006
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 66 (4) , 581-583
- https://doi.org/10.1212/01.wnl.0000198776.53007.2c
Abstract
Fifty-two untreated patients with late-onset Pompe disease completed questionnaires about their clinical condition and level of handicap at baseline and at 1-year (n = 41) and 2-year follow-ups (n = 40). During this period, declines in functional activities, respiratory function, handicap, and survival were recorded on a group level. This study illustrates the progressiveness of late-onset Pompe disease and indicates the need for close clinical follow-up of both children and adults with this disorder.Keywords
This publication has 9 references indexed in Scilit:
- Disease severity in children and adults with Pompe disease related to age and disease durationNeurology, 2005
- Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patientsBrain, 2005
- Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trialNeuromuscular Disorders, 2005
- Enzyme replacement therapy in late‐onset Pompe's disease: A three‐year follow‐upAnnals of Neurology, 2004
- The Natural Course of Infantile Pompe’s Disease: 20 Original Cases Compared With 133 Cases From the LiteraturePediatrics, 2003
- Psychometric evaluation of a new handicap scale in immune‐mediated polyneuropathiesMuscle & Nerve, 2002
- Recombinant human α-glucosidase from rabbit milk in Pompe patientsThe Lancet, 2000
- Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counsellingEuropean Journal of Human Genetics, 1999
- Alpha‐glucosidase deficiency and basilar artery aneurysm: Report of a sibshipAnnals of Neurology, 1987